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Top: Comparison in measured SPIO distribution between PA and 14 Tesla MR imaging
SPIOs mainly distributed in the periphery of the nodal volume (white dotted line). 
Bottom: Node with and without SPIOs after paran embedding and H&E staining.
  
Measured amount of iron within each node (µg) and corresponding µa (mm-1) 
estimated using physical properties of the SPIO and Mie scattering simulations   
Nodal metastasis detection using SPIOs for MR enhancement. 
K. Kimura, Breast Cancer, 2010   
Clinically approved SPIO disperion used 
for pre-operative MR enhancement
Outlook  
      PA detection of SPIOs creates possibilities for intra-operative nodal assessment in oncology 
      Evaluation of concept inside a metastatic animal model in progress
      Rapid implementation into the clinic due to the availibility of clinically approved dispersions
      Towards compact intra-operative imaging modality for resected lymph node assessment 
Tomographic photoacoustic setup 
  Curvilinear 32 element ultrasound detector array
  Central frequency 6.25 MHz with 80% FBW
  Elevation plane focus of 1 mm with axial resolution of 150 µm
   Repetition rate: 10 Hz - Pulse duration: 10 ns
      Projections:  20 (18 degree) - Energy: 20 mJ/cm2 at 720 nm
      Averages: 100 - Slice acquistion time: 200 seconds
      Patient prognosis and treatment based on accurate nodal staging 
  Pre-operative nodal MR staging for different malignancies can be improved      
  using Super Paramagnetic Iron Oxide (SPIO) nanoparticles
      Uptake of SPIOs in healthy nodel tissue compared to absence  
      of uptake in malignant tissue
  Photoacoustically imaging SPIO deposits within nodal tissue 
      could lead to a  fast intra- or pre-operative nodal staging technique  
         
Introduction and Hypothesis
      SPIO nanoparticles proven to improve nodal staging using MRI 
      Optical properties of SPIOs favorable for PA detection
  Clinical approved SPIO dispersions commercially avalaible
  Availibility facilitates rapid clinical applicability 
   
          
Benefit of the approach
Number lymph node 1 2 3 4 5 6
Iron amount (µg) 27 ± 2 51 ± 4 40 ± 3 49 ± 3 30 ± 2 11 ± 1
Absorption coefficient 
µa (mm-1)
0.14 ±
0.01
0.27 ±
0.02
0.21 ±
0.02
0.26 ±
0.02
0.15 ±
0.01
0.06 ±
0.01
MRI Histology Anatomical layout
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      Evaluation in healthy rat model
      Subcutaneous injection of 0.1 ml Endorem® in dorsal side hindleg
      After 24 hours resection of the node
      Photoacoustic and14 Tesla MR imaging of the resected lymph nodes
      Additional verification of SPIO distribution and quantity using H&E 
      staining and Vibrating Sample Magnetometry
      Nodal tissue shows no PA response without contrast injection
  SPIO deposits within nodes possible to map using PA tomography 
      Distribution of SPIOs comparable with results of 14 T MRI and histology
      SPIO deposition mostly in the periphery of the node
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